Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chia-Yu Huang

1PUBLICATIONS

11CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 19, 2024

STING Agonist VB-85247 Induces Durable Antitumor Immune Responses by Intravesical Administration in a Non-Muscle-Invasive Bladder Cancer.

Miglena G Prabagar, Michael McQueney, Venu Bommireddy

Pageof 1

Frequent Collaborators

1 joint publications

Miglena G Prabagar

1 joint publications

Michael McQueney

1 joint publications

Venu Bommireddy

1 joint publications

Rachael Siegel

1 joint publications

Gary L Schieven

1 joint publications

Ku Lu

1 joint publications

Ruziboy Husanov

1 joint publications

Reema Deepak

1 joint publications

David Diller

1 joint publications

Eli Mordechai

Frequent Collaborators

1 joint publications

Miglena G Prabagar

1 joint publications

Michael McQueney

1 joint publications

Venu Bommireddy

1 joint publications

Rachael Siegel

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos